Literature DB >> 2167329

Evidence for separate receptors for insulin and insulin-like growth factor-I in choroid plexus of rat brain by quantitative autoradiography.

D A Davidson1, N J Bohannon, E S Corp, D P Lattemann, S C Woods, D Porte, D M Dorsa, D G Baskin.   

Abstract

Binding of insulin and insulin-like growth factor-I (IGF-I) to the choroid plexus was quantitatively characterized using autoradiography and computer densitometry. Slide-mounted brain slices were incubated in 0.1 nM [125I]-insulin or [125I]-[Thr59]IGF-I. To determine specificity of the binding sites, the labeled peptides were mixed with unlabeled analogues. Autoradiography was done with LKB Ultrofilm and analyzed with a computer image analysis system and program for densitometry. Results showed that binding was time and temperature dependent and reversible. Binding of the iodinated insulin and IGF-I was inhibited by unlabeled peptides in a dose-dependent manner. The rank order of potency of these peptides in competing for the choroid plexus iodoinsulin binding sites was: chicken insulin greater than porcine insulin greater than desoctapeptide insulin greater than IGF-I. IGF-I was more potent than porcine insulin in competing for the choroid plexus iodolGF-I binding sites. Somatostatin was ineffective. Non-linear regression analysis revealed the presence of high- (Kd 1.3 +/- 0.2 nM) and low-affinity (Kd 36 +/- 1.4 nM) binding sites for insulin and a single high-affinity binding site (Kd 3.1 +/- 0.3 nM) for IGF-I in the choroid plexus. There were approximately 50 times more binding sites (Bmax) for IGF-I than for insulin high-affinity sites, whereas the number of low-affinity sites for insulin was about equal to the number of IGF-I high-affinity sites. The results of these binding studies with iodinated insulin and [Thr59]IGF-I support the conclusion that the rat choroid plexus has separate high-affinity receptors for insulin and IGF-I, and that the IGF-I receptors outnumber the insulin receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167329     DOI: 10.1177/38.9.2167329

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  5 in total

1.  Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels.

Authors:  Marta Bolós; Silvia Fernandez; Ignacio Torres-Aleman
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

2.  Release of insulin produced by the choroid plexis is regulated by serotonergic signaling.

Authors:  Caio Henrique Mazucanti; Qing-Rong Liu; Doyle Lang; Nicholas Huang; Jennifer F O'Connell; Simonetta Camandola; Josephine M Egan
Journal:  JCI Insight       Date:  2019-12-05

3.  OB protein binds specifically to the choroid plexus of mice and rats.

Authors:  R Devos; J G Richards; L A Campfield; L A Tartaglia; Y Guisez; J van der Heyden; J Travernier; G Plaetinck; P Burn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 4.  The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome.

Authors:  Iryna Liauchonak; Fady Dawoud; Yatin Riat; Bessi Qorri; Manpreet Sambi; Justin Jain; Regina-Veronicka Kalaydina; Nicole Mendonza; Komal Bajwa; Myron R Szewczuk
Journal:  Int J Mol Sci       Date:  2018-02-17       Impact factor: 5.923

5.  Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase.

Authors:  Joyce H Hurley; Shengwen Zhang; Leighan S Bye; Mark S Marshall; Anna A DePaoli-Roach; Kunliang Guan; Aaron P Fox; Lei Yu
Journal:  BMC Neurosci       Date:  2003-06-09       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.